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As part of a program to study occupational
respiratory disease in the nonindustrial
environment, we investigated building-related
respiratory health in the employees of a large
20-story office building in the northeastern
United States. Since the mid-1990s, the
building had leaked through the roof, around
windows, and through sliding doors of ter-
races. The upper ﬂoors had suffered the most
water damage and mold contamination.
During investigation of these problems, the
building was found to be operating at a nega-
tive pressure with respect to the outdoors,
which could exacerbate water incursion
through the building envelope. Furthermore,
there had been plumbing leaks on many
ﬂoors which had damaged interior walls. The
first major construction activity related to
water incursion began in 2000, with repair of
roof copings and brick caulking. From 2000
to 2002, cubicle partitions and carpets were
cleaned, wetted carpet and stained wallboard
replaced, wallpaper and underlying mold
removed from bathrooms, upgrades to the air
handling system made, and windows caulked.
In 2002, permanent repairs on the building
exterior, including roof replacement, began to
prevent water incursion.
Building occupants had reported health
conditions that they considered building
related. Symptom onset spanned several
years, with an increase in symptoms and fre-
quency of complaints beginning in the fall of
2000. Sentinel cases of postoccupancy-onset
asthma, hypersensitivity pneumonitis (HP),
and sarcoidosis had been diagnosed, and the
persons affected had been relocated to
another facility. HP is an immune-regulated
granulomatous disease that has been associ-
ated with fungal contamination, and it has
been found to coexist with asthma in damp
office buildings (Arnow et al. 1978; Kreiss
1989; Hoffman et al. 1993; Jarvis and Morey
2001). Sarcoidosis is an immune-regulated
granulomatous disease of unknown etiology. 
In this article we report evidence of
excesses of respiratory symptoms and physician
diagnosis of asthma in the occupants of the
water-damaged building as well as veriﬁcation
of self-reported respiratory illness with objec-
tive testing. We also describe the burden of ill-
ness in terms of absences, use of breathing
medications, and health-related quality of life.
Methods and Materials
Study design and population. In September
2001, we offered a questionnaire to all 1,327
employees working in the building. The ques-
tionnaire was administered to groups of
approximately 50 employees at a time, using
schedules prepared by management. During
each group session, National Institute for
Occupational Safety and Health (NIOSH)
staff described the purpose of the survey and
the consent process and read the questions
aloud from overhead transparencies as the par-
ticipants completed them. By completing the
questionnaire, the participants were indicating
consent to take part in the survey. The ques-
tionnaire comprised sections on demographics;
symptoms (upper and lower respiratory, sys-
temic, headache, and difﬁculty concentrating)
in the last 4 weeks and 12 months, and in rela-
tion to being in the building; physician diag-
nosis of asthma, HP, and sarcoidosis, with
dates of diagnosis; smoking history; and work
history in the building. The completed ques-
tionnaires were electronically scanned into a
database and hand-checked for quality control. 
We used the September questionnaire to
identify a group of employees who had worked
in the building for at least 1 year and who met
either an epidemiologic case definition for
lower respiratory illness or a comparison group
deﬁnition. The respiratory case deﬁnition was
three or more of ﬁve lower respiratory symp-
toms (wheeze/whistling in the chest, chest
tightness, shortness of breath, coughing, awak-
ening by attack of breathing difﬁculty) occur-
ring weekly over the past month; or at least
two of three symptoms consistent with HP
(shortness of breath when hurrying on level
ground or walking up a slight hill, fever and
chills, ﬂulike achiness or achy joints) occurring
weekly over the past month; or current asthma
with postoccupancy physician diagnosis, or
physician-diagnosed HP or sarcoidosis. The
comparison group deﬁnition was none of the
respiratory case lower respiratory or HP-like
symptoms in the past year and none of the
respiratory case diagnoses. 
We invited the 202 employees who met
the case deﬁnition and the 154 employees who
met the comparison group deﬁnition to partic-
ipate in a questionnaire and medical testing
survey in June 2002. During the site visit, an
additional 15 employees asked to take part in
the survey. All participants provided written
informed consent (approved by the NIOSH
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We conducted a study on building-related respiratory disease and associated social impact in an
ofﬁce building with water incursions in the northeastern United States. An initial questionnaire
had 67% participation (888/1,327). Compared with the U.S. adult population, prevalence ratios
were 2.2–2.5 for wheezing, lifetime asthma, and current asthma, 3.3 for adult-onset asthma, and
3.4 for symptoms improving away from work (p < 0.05). Two-thirds (66/103) of the adult-onset
asthma arose after occupancy, with an incidence rate of 1.9/1,000 person-years before building
occupancy and 14.5/1,000 person-years after building occupancy. We conducted a second survey
on 140 respiratory cases, 63 subjects with fewer symptoms, and 44 comparison subjects. Health-
related quality of life decreased with increasing severity of respiratory symptoms and in those with
work-related symptoms. Symptom status was not associated with job satisfaction or how often
jobs required hard work. Respiratory health problems accounted for one-third of sick leave, and
respiratory cases with work-related symptoms had more respiratory sick days than those without
work-related symptoms (9.4 vs. 2.4 days/year; p < 0.01). Abnormal lung function and/or breath-
ing medication use was found in 67% of respiratory cases, in 38% of participants with fewer
symptoms, and in 11% of the comparison group (p < 0.01), with similar results in never-smokers.
Postoccupancy-onset asthma was associated with less atopy than preoccupancy-onset asthma.
Occupancy of the water-damaged building was associated with onset and exacerbation of respira-
tory conditions, conﬁrmed by objective medical tests. The morbidity and lost work time burdened
both employees and employers. Key words: building-related symptoms, hypersensitivity pneu-
monitis, indoor environment, occupational asthma, ofﬁce workers, quality of life, sarcoidosis, sick
leave. Environ Health Perspect 113:485–490 (2005). doi:10.1289/ehp.7559 available via
http://dx.doi.org/ [Online 20 January 2005]Human Subjects Review Board). We used
results of the June questionnaire to reclassify
participants into the respiratory case or com-
parison groups. Participants who reported
lower respiratory or systemic symptoms but
who did not meet the criteria of a respiratory
case formed a third, “fewer symptoms” group.
Questionnaire. Participants completed an
interviewer-administered computer-based
questionnaire. The June 2002 questionnaire
included sections on demographics, work his-
tory, health and symptom history, physician
diagnoses, smoking, home environment, and
job stress and satisfaction as used in the U.S.
Environmental Protection Agency (EPA)
Building Assessment Survey and Evaluation
(BASE) study (U.S. EPA 1994), and health-
related quality of life from the SF-12 (Medical
Outcomes Study, Short Form; Ware et al.
1996). We included questions on the use of
beta-agonist and corticosteroid inhalers, over-
the-counter breathing medications, and other
asthma medications in the previous 4 weeks, as
well as oral corticosteroid use in the previous
12 months, adapted from an asthma-severity
score module (Blanc et al. 1996). To help with
recall, participants were asked to bring to their
testing session a list of the medications that
they were taking for breathing problems. 
Spirometry. Qualiﬁed technicians followed
standard guidelines for spirometry (American
Thoracic Society 1995). We compared the test
results to expected values for a healthy, non-
smoking person of the same age, height, sex,
and race using spirometry reference values and
95% normal conﬁdence intervals (CIs) gener-
ated from the third National Health and
Nutrition Examination Survey (NHANES
III) (Hankinson et al. 1999). Abnormal test
results were categorized as having a pattern of
obstruction, restriction, or a “mixed” pattern
of both airways obstruction and a low forced
vital capacity (FVC) (American Thoracic
Society 1995). We defined airways obstruc-
tion as a low forced expiratory volume in 1 sec
(FEV1) to FVC ratio (FEV1/FVC%) with low
FEV1. We defined restriction as a low FVC
and normal FEV1/FVC%.
Methacholine challenge testing. To detect
bronchial hyperresponsiveness (BHR), we per-
formed methacholine challenge testing
(MCT) using standardized techniques (Crapo
et al. 2000) with 0.125, 0.5, 2, 8, and
32 mg/mL methacholine. Five breaths of neb-
ulized methacholine were administered for
each dose, with FEV1 measured 30 and 90 sec
later. If FEV1 dropped > 20% of the baseline
value, no further methacholine was given. We
report methacholine dose as PC20, which is
the provocative concentration of methacholine
that causes an interpolated 20% decline in
FEV1 from the baseline. We deﬁned BHR as a
PC20 of ≤ 4.0 mg/mL, and borderline BHR as
a PC20 between 4.1 and 16.0 mg/mL (Crapo
et al. 2000). 
Bronchodilator testing. In subjects with
baseline FEV1 < 70% of the predicted value,
MCT was not performed, but a broncho-
dilator test was performed to detect any
reversible bronchoconstriction. Two puffs of
a beta-agonist were administered via metered
dose inhaler and were followed by spirometry.
We defined reversibility as a 12% and
200 mL FEV1 improvement after broncho-
dilator administration (American Thoracic
Society 1991).
Allergen skin prick testing. We applied
extracts of seven common indoor and outdoor
allergens and three mold mixes using the
GreerPIK system (Greer Laboratories, Lenoir,
NC): dust mite mix (Dermatophagoides farinae
and D. pteronyssinus), German cockroach
(Blattella germanica), cat hair, seven grass mix,
ragweed mix, common weed mix, Eastern eight
tree mix, Dematiaceae mix (outdoor molds:
Alternaria tenuis, Cladosporium herbarum,
Helminthosporium sativum, Pullularia pullulans,
Spondylocladium atrovirens, Curvularia
spicifera), Aspergillus mix, and Penicillium mix.
The negative control was 50% glycerin in
water, and histamine served as a positive con-
trol. For each wheal, the mean diameter (aver-
age of the length and width) at 15 min was
calculated. We deﬁned a positive reaction as an
average diameter at least 3 mm larger than the
negative control and > 25% of the average
diameter of the positive control. For the pur-
poses of this study, atopy was deﬁned as at least
one positive skin test on allergy testing, using a
total of seven common antigen extracts
(excluding the mold mixes).
Data analysis. We compared the prevalence
rates of respiratory symptoms and self-reported
medical diagnoses observed in the building
occupants during the September 2001 survey to
the U.S. adult prevalence rates obtained from
NHANES III [National Center for Health
Statistics (NCHS) 1996], the 2001 data for
Connecticut from the Behavioral Risk Factor
Surveillance System (BRFSS) (National Center
for Chronic Disease Prevention and Health
Promotion Behavioral Risk Factor Surveillance
System 2001), and data for occupants of
41 office buildings with no known indoor
environmental problems (Apte et al. 2000).
For comparisons with NHANES III, we used
indirect standardization for race (black,
Hispanic, white), sex, age (17–39 years of age
versus 40–69 years of age), and cigarette smok-
ing status (current, former, or never smoker).
For comparisons with BRFSS, we standardized
for sex. We derived 95% CIs using a method
that assumes that the observed data are from a
Poisson distribution (Kahn 1989).
To estimate incidence density rates of
physician-diagnosed adult-onset asthma, for
each participant we calculated person-time at
risk for two time periods: from 16 years of age
to building occupancy and from building
occupancy to the September 2001 survey
date. For subjects with physician-diagnosed
adult-onset asthma, time at risk ended on the
date of diagnosis. Time at risk for each
participant was summed to give person-years
at risk. Participants with childhood asthma
did not contribute any time at risk. 
We used SAS software (version 8.02; SAS
Institute Inc. Cary, NC) to analyze the data.
Chi-square tests were used in statistical analy-
sis of two-way classification tables. We used
the Cochran-Mantel-Haenszel test in analysis
of differences between proportions after
adjustment for smoking, and we used the
Cochran-Armitage test in analysis for linear
trends in proportions. We used the SAS GLM
procedure to model number of days lost and
Duncan’s multiple range test for multiple
means comparisons.
Results
September 2001 Survey
Participation. Participation was 67%
(888/1,327) in the cross-sectional question-
naire study. Participants were predominantly
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Table 1. Demographics of 888 participants in the
September 2001 questionnaire survey.
Proportion
Characteristic or measure
Female (%) 59
Age [years (mean ± SD)] 46 ± 9
Race (%)
White 74
Black 19
Hispanic 6
Building occupancy [years (mean ± SD)] 6 ± 2
Current smoker (%) 14
Never smoker (%) 62
Table 2. Comparison of health outcomes prevalences with NHANES III (NCHS 1996).
Building Prevalence
Standardized questions  prevalence [% (n)] ratio 95%  CI
Asthma ever 17.7 (143/810) 2.2 1.9–2.6
Asthma current 12.8 (103/804) 2.4 2.0–3.0
Wheezing or whistling in your chest in the last 12 months 35.9 (291/811) 2.5 2.2–2.8
Stuffy, itchy, or runny nose in the last 12 monthsa 79.3 (643/811) 1.5 1.4–1.6
Watery, itchy eyes in the last 12 months 63.4 (510/804) 1.6 1.4–1.7
Wheezing, nose, or eye symptoms better on days off work 72.1 (468/649) 3.4 3.1–3.7
The prevalence ratios were adjusted for age, sex, race, and smoking category; missing information on these characteris-
tics led to comparisons based on fewer than the total 888 participants.
aOur question included sneezing.white, in their mid-forties, former or never
smokers, who had been working in the build-
ing for about 6 years (Table 1). We had demo-
graphic and participation information on the
689 employees working for one of the two
building tenant organizations. These employ-
ees had a mean age of 45 years, and 74% were
white, 19% were black, and 53% were female.
There was 76% participation among these
employees. Comparison between participants
and nonparticipants showed no differences in
mean age or race. There were proportionately
more females among participants than among
nonparticipants (57% vs. 40%, p < 0.01).
Excess respiratory symptoms and physician-
diagnosed asthma. In comparisons with the
U.S. adult population, prevalence ratios ranged
from 2.2 to 2.5 for wheezing, lifetime asthma,
and current asthma (p < 0.05; Table 2). Nasal
and eye symptoms were more prevalent in the
building occupants than lower-respiratory
symptoms, but were less elevated compared to
U.S. adults (prevalence ratios 1.5 and 1.6,
respectively, p < 0.05). The building occupants
reported wheeze, nasal, or eye symptoms that
improved when they were away from work at
3.4 times the rate of the U.S. population
(p < 0.05). Compared to the state adult popu-
lation, prevalence ratios were 1.4 (95% CI,
1.2–1.6) for lifetime asthma, and 1.5 (95% CI,
1.3–1.9) for current asthma. A majority
(60–70%) of participants with wheeze, chest
tightness, shortness of breath, or cough in the
last 4 weeks reported an improvement in
symptoms when away from the building.
Prevalence ratios for work-related lower respi-
ratory symptoms compared to U.S. office
workers were elevated and ranged from 2.7 to
4.7 (p < 0.05; Table 3). 
Adult onset asthma prevalence and inci-
dence. The prevalence of adult-onset asthma
was 12% (103/865). A comparison to the U.S.
adult population gave a prevalence ratio of 3.3
(95%, CI 2.7–4.0). Two-thirds (66/103) of
the adult-onset asthma occurred after occu-
pancy of the building. An analysis of adult-
onset asthma incidence density was conducted
based on 19,173 person-years at risk before
building occupancy and 4,564 person-years at
risk after building occupancy. We found inci-
dences of 1.9 per 1,000 person-years in the
period before building occupancy and 14.5 per
1,000 person-years in the period after building
occupancy. The incidence rate ratio was 7.5,
indicating a large increase in asthma incidence
in the period after building occupancy.
Asthma symptom severity and exacerba-
tion. The participants with postoccupancy-
onset, physician-diagnosed asthma had a
higher mean value for the sum of cough,
wheeze, chest tightness, and shortness of breath
occurring once or more per week in the last
4 weeks than any other participants (p < 0.05).
There was also a signiﬁcant trend (p < 0.01) in
prevalence of lower respiratory symptoms that
improved when away from the building: 52%
of those with postoccupancy-onset asthma,
41% of those with adult preoccupancy-onset
asthma, 27% of those with childhood asthma,
and 23% of those with no physician-diagnosed
asthma (Table 4). 
HP and sarcoidosis. Eight participants
reported HP, five with postoccupancy-onset
and one with preoccupancy-onset HP (two
people did not give diagnosis dates).
Sarcoidosis was reported by six participants,
three with postoccupancy onset, and two with
preoccupancy onset (one person did not give a
date of diagnosis). Fever and chills were
reported as occurring once or more in the last
4 weeks by 9%, ﬂulike achiness or achy joints
by 22%, and excessive fatigue by 29% of par-
ticipants. A work-related pattern was noted by
22% of those with fever and chills, by 30% of
those with ﬂulike achiness or achy joints, and
by 52% of those with excessive fatigue.
June 2002 Survey
Participation. There were 248 participants in
the June 2002 survey. Participation was
higher among the invited employees meeting
the respiratory case definition in September
2001 (142/202; 70%) than among the com-
parison group invitees (91/154; 59%). Based
on the June 2002 questionnaire results, there
were 140 participants in the respiratory case
group, 63 participants in the fewer symptoms
group, and 44 participants in the comparison
group. One participant had missing question-
naire information and could not be classiﬁed.
A little more than half of those asymptomatic
in September 2001 reported symptoms
9 months later, with 17% achieving respira-
tory case status, and 38% falling into the fewer
symptoms group. In contrast, a majority
(81%) of those meeting the respiratory case
definition in September 2001 still met this
definition 9 months later, 17% fell into the
intermediate group, and 2% became asympto-
matic. The demographics of the June 2002
participants stratiﬁed by respiratory status are
given in Table 5. There were more females
and more current smokers in the respiratory
case group. 
Lung function tests, breathing medica-
tion use, and reported respiratory health.
Respiratory cases had the highest proportions
of abnormal breathing tests and breathing
medication use; the fewer symptoms group
had the next highest; and the comparison
group had the lowest proportions of these two
outcomes (Tables 6 and 7). Test results indi-
cated more obstruction than restriction, and
the respiratory cases had a trend for a higher
prevalence of obstruction than the other par-
ticipants. BHR was higher in the two groups
with symptoms than in the comparison group,
but this ﬁnding was not signiﬁcantly different.
Environmental Medicine | Respiratory morbidity in office workers
Environmental Health Perspectives • VOLUME 113 | NUMBER 4 | April 2005 487
Table 5. Demographics of June 2002 participants by respiratory symptom status.
Respiratory case Fewer symptoms Comparison
group (n = 140) group (n = 63) group (n = 44)
Female (%)** 73 44 59
Age [years (mean ± SD)] 47 ± 8 46 ± 9 46 ± 8
Occupancy duration [years (mean ± SD)] 7 ± 2 7 ± 2 7 ± 2
Current smoker (%) 17 6 9
Never smoker (%) 56 70 70
Due to missing values, age and duration of occupancy in respiratory case group are based on 137 participants. For age,
n = 62 in the fewer symptoms group and n = 42 in the comparison group.
**p = 0.0004 by Chi-square test on sex.
Table 4. Mean number of lower respiratory symptoms and prevalence of work-related symptoms in the
last 4 weeks by asthma status and onset period.
Preoccupancy
Postoccupancy- adult-onset Childhood-onset No reported
onset asthma asthma asthma asthma
Number of lower respiratory 1.7 ± 1.6A 1.1 ± 1.3B 0.7 ± 1.3B,C 0.5 ± 0.9C
symptoms (mean ± SD)a
Work-related lower 34/66 (52)** 15/37 (41)  8/30 (27) 169/731 (23)
respiratory symptoms [n (%)]
Lower respiratory symptoms include wheeze, cough, chest tightness, and shortness of breath. 
aMeans with the same letter are not significantly different at α = 0.05, using Duncan's multiple-range test. **Cochran-
Armitage trend test p < 0.0001.
Table 3. The prevalence of work-related lower respiratory symptoms that occurred frequently in the previ-
ous 4 weeks, compared to U.S. ofﬁce workers.
Prevalence (%) Prevalence ratioa 95% CI
Wheezing 6.9 2.9 2.2–3.7
Coughing attacks 14.8 2.7 2.3–3.2
Chest tightness 11.3 4.7 3.8–5.7
Shortness of breath 9.6 4.6 3.7–5.7
aThe prevalence of the 888 study participants compared with results from 41 nonproblem buildings (Apte et al. 2000).We found very little breathing medication use
reported by the comparison group as com-
pared to almost half of the respiratory cases.
Analyses on the never-smokers showed similar
trends, with a prevalence of abnormal lung
function tests and medication use combined
of 71% for respiratory cases, 30% for partici-
pants with fewer symptoms, and 12% for the
comparison group.
Quality of life. We compared responses to
health-related quality-of-life questions among
the three symptom status groups. We found
statistically significant trends for increasing
impairment in health-related quality of life
with increasing severity of respiratory symp-
toms. The largest differences were seen for
reported physical limitations (Figure 1).
Within the respiratory case and the fewer
symptoms groups, we found statistically sig-
niﬁcant poorer health-related quality of life in
relation to the presence of work-related symp-
toms, except for general health status
(Figure 2). Similar results were found for
health-related quality of life and postoccu-
pancy symptom onset, except that statistical
differences were seen for limitations in climb-
ing stairs, physical health-limiting accom-
plishments, and physical health limiting the
kind of activities.
Job stress/dissatisfaction. There were no
statistical differences among symptom status
groups for responses on job satisfaction or
how often a person was required to work
hard. Being very or somewhat satisfied with
their job was reported by 87% of respiratory
cases, 90% of the group with fewer symptoms
and 93% of the comparison group. Being
required to work hard frequently or very often
was reported by 51% of respiratory cases, 62%
of the intermediate group, and 45% of the
comparison group.
Work days lost. The number of days off
work in the last 12 months due to respiratory
problems was significantly associated with
symptom status (p < 0.01). The respiratory
cases had missed a mean of 6.9 days as com-
pared to 1.7 days for the group with fewer
symptoms and 2.0 days for the asymptomatic
group. We found that 34% of respiratory
cases had ≥ 6 days of respiratory sick leave,
compared to 11% of the fewer symptoms
group and 4.7% of the asymptomatic com-
parison group (p < 0.01). In contrast, there
was no statistically significant difference
between the three groups for nonrespiratory
sick leave. The respiratory cases lost a mean of
4.5 days, the group with fewer symptoms lost
7.5 days, and the asymptomatic group lost
4.1 days due to nonrespiratory conditions. 
The number of respiratory sick days was
similar for symptomatic participants regardless
of whether the onset was pre- or post-
occupancy. A large effect was seen for having
respiratory symptoms that improved away
from the building. Respiratory cases with
work-related respiratory symptoms had more
respiratory sick days than those with symp-
toms that did not improve away from the
building (9.4 vs. 2.4, p < 0.01). In the group
with fewer symptoms, those with work-related
respiratory symptoms had more respiratory
sick leave than those with symptoms with no
work-related pattern (3.7 vs. 1.1, p < 0.05). 
We estimated sick days over the past year
for respiratory conditions and total sick leave
for building occupants by applying the mean
work days missed for the three symptom
groups to the number of participants in those
categories from the September 2001 question-
naire (816 participants had adequate data).
Respiratory health problems accounted for
34% of sick leave days (2,490/7,402). The res-
piratory case group represented 25% of the
September 2001 participants but contributed
56% (1,401/2,490) of the respiratory sick leave
days. Using the mean of 2 days of respiratory
sick leave reported by the comparison group as
a non–building-related baseline for building
occupants gives an estimated 858 days of
excess respiratory sick leave (2,490–1,632).
Thus, up to 12% (858/7,402) of the preced-
ing 12 months of employee sick leave days
might have been attributable to building-
related effects.
Breathing medication use. We looked at
the prevalence of the use of asthma-controller
medications (inhaled corticosteroids, cro-
molyn, nedocromil, oral antileukotrienes) and
reliever medications (short-acting beta-agonists
and ipratropium bromide) in the last 4 weeks
in participants with physician-diagnosed
asthma for comparison with a national sample
of 1,788 U.S. adults with current asthma
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Table 6. Breathing test results for participants, stratiﬁed by symptom status in June 2002.
Variable Respiratory cases group Fewer symptoms group Comparison group
Spirometry testing [% (n)]a
Abnormal 24 (31/131)b 13 (8/62) 7 (3/42)
Obstructed or mixed 15 (20/131) 6 (4/62) 7 (3/42)
Restriction (low FVC) 8 (11/131) 6 (4/62) 0 (0/42)
Percent predicted FEV1 (mean ± SD) 92 ± 16c 96 ± 17 103 ± 12
Percent predicted FVC (mean ± SD) 94 ± 14d 97 ± 16 103 ± 11
Methacholine challenge testing [% (n)]
Abnormal (< 16 mg/mL)  19 (19/99) 20 (10/51) 6 (2/36)
< 4 mg/mL (BHR) 6 (6/99) 8 (4/51) 0 (0/36)
> 4 and < 16 mg/mL (borderline BHR) 13 (13/99) 12 (6/51) 6 (2/36)
Bronchodilator testing positive [% (n)] 18 (2/11) ND ND
Abnormal methacholine challenge or bronchodilator tests  [% (n)] 19 (21/110) 20 (10/51) 6 (2/36)
Any abnormal lung function test [% (n)]e 39 (44/114)f 29 (16/55) 11 (4/37)
ND, not done.
aTwo invalid tests by the symptomatic participants were not included. bAcross the row there was a signiﬁcant Cochran-Armitage trend test (p < 0.01); the signiﬁcant differences by
symptom status remained after adjusting for smoking category (Cochran-Mantel-Haenszel test; p < 0.05). cIn a linear regression model adjusting for smoking category, there was a sig-
niﬁcant effect of symptom status (p < 0.01); the group meeting the respiratory case deﬁnition had a lower mean percent predicted FEV1 than either of the other two groups. dIn a linear
regression model adjusting for smoking category, there was a signiﬁcant effect of symptom status (p < 0.01); the group that met the respiratory case deﬁnition had a lower mean percent
predicted FVC than the asymptomatic group. eParticipants who had either a negative spirometry or a negative methacholine/bronchodilator test and who had not done the other tests were
excluded. fAcross the row there was a signiﬁcant Cochran-Armitage trend test (p < 0.01); the signiﬁcant differences by symptom status remained after adjusting for smoking category
(Cochran-Mantel-Haenszel test; p < 0.01).
Table 7. Medication usage and combined medication usage and abnormal lung function [% (n)] stratiﬁed
by symptom status in June 2002.
Respiratory Fewer Comparison
cases group a symptoms group
Any medication for breathing problems 46 (65/140) 13 (8/63) 2 (1/44)
Oral steroids 21 (29/140) 8 (5/63) 2 (1/44)
Inhaled steroids 19 (27/140)  2 (1/63) 0 (0/44)
Beta-agonists 28 (39/140) 2 (1/63) 0 (0/44)
Positive for any medication for breathing problems or 67 (83/124) 38 (21/55) 11 (4/37)
an abnormal lung function test
aAcross all rows there were signiﬁcant Cochran-Armitage trend tests (p < 0.01); the signiﬁcant differences by symptom
status remained after adjusting for smoking category (Cochran-Mantel-Haenszel tests; p < 0.01).(Adams et al. 2002; Fuhlbrigge et al. 2002)
using two-sample tests of proportions. Use of
an asthma controller was reported by 39% of
our study group versus 21% of U.S. asthma
cases overall (p < 0.01). The prevalence of
39% asthma-controller use was marginally
higher (p = 0.07) than the value of 29%
reported for U.S. cases with severe persistent
symptoms in the last 4 weeks. Reliever use was
reported by 50% of our group versus 63% of
U.S. cases (p < 0.05). 
Skin prick allergy tests. Over half of the par-
ticipants met the deﬁnition for atopy. There
was no statistical difference in the prevalence
of atopy among the respiratory case group, the
group with fewer symptoms, and the compari-
son group. However, preoccupancy-onset
asthma was associated with a higher preva-
lence of atopy (p < 0.05). The results of indi-
vidual skin prick allergen tests showed that
persons with preoccupancy-onset asthma had
a higher prevalence of positive reactions to cat,
dust mites, and weed mix (p < 0.01) as well as
to cockroach allergens (p < 0.05). We found
that the postoccupancy-onset asthma cases
had the lowest reaction to the mold mixes
(p = 0.05; Figure 3).
Discussion
Physician-diagnosed asthma and respiratory
symptoms occurred in excess among our
study participants and was confirmed by an
excessive rate of airway obstruction and BHR.
Studies of building occupants with known
health concerns are subject to reporting bias. In
our study, in addition to reported symptoms
and physician diagnoses, we examined meas-
ures of respiratory disease, including medica-
tion use and medical tests. Two-thirds of those
classiﬁed as respiratory cases based on symp-
toms or physician diagnoses had objective pul-
monary function abnormalities or used
prescription medications for breathing diffi-
culties (given with the goal of normalizing
lung function). The higher rate of lung func-
tion abnormalities and breathing medication
use in the participants reporting respiratory
symptoms validates the symptom reports. 
The majority (60–70%) of participants
with respiratory symptoms reported a work-
related pattern, implying a building-related
exposure. The 7% overall prevalence of work-
related wheeze was higher than the 2–4% in
studies of nonproblem buildings (Apte et al.
2000) and higher than the 2–6% found in
studies of problem buildings (Malkin et al.
1996). In the 9-month interval between the
building-wide questionnaire survey and the
nested case–control survey, more than half
(55%) of the comparison group chosen because
they had no lower respiratory or systemic
symptoms in September 2001 had become
symptomatic, including 17% who were classi-
ﬁed as respiratory cases. Improvement was rare
in September 2001 cases (17%), suggesting a
continued effect of building occupancy on res-
piratory health. Some of this response pattern
may be attributable to overreporting due to
general concern about water incursions and
sentinel cases with health effects, but such
concerns had been present since before the
September 2001 survey.
The estimated incidence of physician-
diagnosed, adult-onset asthma among the
study participants (1.9 per 1,000 person-years)
before building occupancy was within the
range of other estimates for adults, for exam-
ple, 2.1 per 1,000 person-years (McWhorter
et al. 1989), 3.8 per 1,000 person-years (Sama
et al. 2003), and about 1 per 1,000 person-
years (Reed 1999). In contrast, after building
occupancy, incidence rose 7.5 times to 14.5
per 1,000 person-years, consistent with the
symptoms that developed in the previously
asymptomatic comparison group. 
The burden of respiratory problems in
this population was reflected in substantial
respiratory sick leave attributable to building
occupancy (estimated at 12% of total). The
presence of work-related respiratory symp-
toms was positively associated with respira-
tory sick leave, but time of symptom onset
was not, suggesting that having a work-related
pattern to respiratory symptoms was a larger
determinant of respiratory sick leave than
whether the symptoms arose before or after
building occupancy. 
The proportion of our study respiratory
cases with ≥ 6 days of respiratory sick leave
was 34%. In comparison, a population study
of 1,788 adults with asthma in the United
States found that 11% of participants had
≥ 6 days of sick leave in the past year related to
their asthma (Fuhlbrigge et al. 2002). In our
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Figure 1. Quality-of-life comparisons among symptom
groups. 
**p < 0.01, Cochran-Armitage trend test.
70
60
50
40
30
20
10
0
P
e
r
c
e
n
t
a
g
e
**
G
e
n
e
r
a
l
 
h
e
a
l
t
h
 
f
a
i
r
 
t
o
 
p
o
o
r
E
m
o
t
i
o
n
a
l
 
h
e
a
l
t
h
 
h
a
s
 
l
i
m
i
t
e
d
t
h
e
 
k
i
n
d
 
o
f
 
a
c
t
i
v
i
t
i
e
s
E
m
o
t
i
o
n
a
l
 
h
e
a
l
t
h
 
h
a
s
 
l
i
m
i
t
e
d
a
c
c
o
m
p
l
i
s
h
m
e
n
t
P
h
y
s
i
c
a
l
 
h
e
a
l
t
h
 
h
a
s
 
l
i
m
i
t
e
d
t
h
e
 
k
i
n
d
 
o
f
 
a
c
t
i
v
i
t
i
e
s
P
h
y
s
i
c
a
l
 
h
e
a
l
t
h
 
h
a
s
 
l
i
m
i
t
e
d
a
c
c
o
m
p
l
i
s
h
m
e
n
t
L
i
m
i
t
e
d
 
i
n
 
c
l
i
m
b
i
n
g
 
s
t
a
i
r
s
L
i
m
i
t
e
d
 
i
n
 
m
o
d
e
r
a
t
e
 
a
c
t
i
v
i
t
y
Respiratory cases group
Fewer symptoms group
Comparison group
**
**
**
**
**
**
Figure 2. Quality of life in the respiratory case
group and the fewer symptoms group, stratiﬁed by
work-relatedness of symptoms. 
*p < 0.05 and **p < 0.01, Chi-square test.
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Figure 3. Allergy skin test results by asthma diag-
nosis.
*p < 0.05 and **p < 0.01, Chi-square test.
100
90
80
70
60
50
40
30
20
10
0
P
e
r
c
e
n
t
a
g
e
 
s
k
i
n
 
p
r
i
c
k
 
p
o
s
i
t
i
v
e
G
r
a
s
s
e
s
No reported asthma
Pre occupancy-onset asthma
Post occupancy-onset asthma
*
*
T
r
e
e
s
R
a
g
w
e
e
d
R
o
a
c
h
W
e
e
d
s
D
u
s
t
 
m
i
t
e
s
C
a
t
A
t
o
p
i
c
M
o
l
d
s
**
**
**study, respiratory cases had a mean of 6.9 res-
piratory sick days, compared to 4.4 annual
work absences because of breathing problems
among Canadian asthmatics (Ungar and
Coyte 2000). In the Canadian study more
productivity was lost due to a decrease in level
of functioning at work on days when breath-
ing problems were worse than usual than due
to days off work. Although we have no esti-
mate of productivity loss due to a decrease in
functioning at work for our study participants,
the high prevalence of work-related symptom
exacerbation suggests a substantial decrease in
productivity might have occurred. High respi-
ratory morbidity was also indicated by the
high use of asthma-controller medication and
the decreased prevalence of quick-relief med-
ications. This pattern of medication use is
consistent with persistent asthma associated
with daily work-related exacerbation. 
We found strong associations between
respiratory symptom status and lower health-
related quality of life, confirming the social
burden of respiratory morbidity in building
occupants. In contrast, we found no relation
between job stress, job satisfaction, or per-
ceived work burdens with symptom status;
this is consistent with the ﬁndings of another
investigation of building-related respiratory
disease (Jarvis and Morey 2001) and reduces
the likelihood that disgruntled employees in a
problem building exaggerate their symptoms. 
The specific etiology and mechanisms of
the respiratory disease in this building remain
undeﬁned. The skin prick test results for imme-
diate hypersensitivity responses to common
aeroallergens were unexpected. Preoccupancy-
onset asthma was associated with atopy, as
anticipated [National Asthma Education and
Prevention Program (NAEPP) 1997; Peden
2000]. However, postoccupancy-onset asthma
cases had much lower prevalence of IgE-
mediated allergen skin-test positivity (atopy).
Perhaps the airway inﬂammation was not dri-
ven by an IgE mechanism. It is possible that
nonbiologic irritant exposures were present,
and furthermore, although molds have aller-
genic properties (Lander et al. 2001), the
development of asthma in damp/moldy condi-
tions may not be IgE mediated (Douwes et al.
2003; Savilahti et al. 2001). 
The rarity of clusters of HP in the general
population points to a work-related etiology
for the cluster in the building occupants. The
recent Institute of Medicine report on damp
indoor spaces and health found sufﬁcient evi-
dence for an association between mold or
other agents in damp indoor environments
and upper respiratory tract symptoms, cough,
wheeze, asthma symptoms in sensitized per-
sons, and HP in susceptible persons (Institute
of Medicine 2004). The cluster of sarcoidosis
raises concern that this granulomatous lung
disease was misdiagnosed HP (Forst and
Abraham 1993) or has overlapping environ-
mental causes (Kucera et al. 2003). 
The major limitation of the present study
is the possible inﬂuence of participation bias.
We had a 67% participation in our September
2001 survey, and differences in health status of
participants and nonparticipants could have
led to overestimation of symptom and asthma
prevalence, particularly since women were
more likely to be participants. Using the most
conservative approach, we compared mini-
mum possible prevalences among the entire
building population to the external reference
populations. We still found excesses of asthma
and symptoms in comparison to the U.S. pop-
ulation and to ofﬁce workers in buildings not
known to have indoor environmental prob-
lems (data not shown), but we found no differ-
ences in asthma prevalence in comparison to
the state population. Counterbalancing possi-
ble response bias among those occupants who
participated in our study is our ﬁnding of gra-
dients of nonsubjective tests and reported med-
ication use in relation to symptom intensity.
In conclusion, the present study con-
tributes to the growing literature that water-
damaged buildings can be associated with
work-related respiratory disease. This investi-
gation documents the considerable respiratory
illness, adverse effects on quality of life, and
absenteeism that have placed personal, social,
and economic burdens on many employees
and their employers. Building-related respira-
tory disease warrants increased public health,
medical research, and policy attention.
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